Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
Moderna says its long-running patent dispute with Pfizer and BioNTech isn't over even after a decision by an administrative ...
4d
CNET on MSNHow the 3 New COVID Vaccines Change the Way You PayNow that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...
Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from Genevant Sciences and Arbutus Biopharma targeting its LNP technology used in products like ...
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In ...
The pandemic's volatility affected all public companies, but some saw their business deeply transformed. Here's how three of ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
The police and fire-rescue departments partnered with the town manager’s office to guide the town’s COVID-19 response.
Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore ...
A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results